The purpose of this study is to investigate whether SFN treatment could influence macrophage foam cell formation and atherosclerosis and explore the potential mechanistic contribution of CD36, ABCA1/G1 expression and the involvement of PPARγ and Nrf2. The gene discussed is CD36; the disease is atherosclerosis.